Stem Cell Transplant Complications Recruiting Phase 2 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0081111 (Stem Cell Transplant Complications)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03214354Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling DonorTreatment